GLRA
Gerald L. Ray & Associates’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $7.51M | Buy |
199,260
+2,480
| +1% | +$93.4K | 0.94% | 24 |
|
|
2017
Q2 | $5.49M | Buy |
196,780
+13,130
| +7% | +$366K | 0.71% | 34 |
|
|
2017
Q1 | $6.31M | Buy |
183,650
+3,370
| +2% | +$116K | 0.86% | 29 |
|
|
2016
Q4 | $5.2M | Buy |
180,280
+14,990
| +9% | +$432K | 0.75% | 32 |
|
|
2016
Q3 | $5.26M | Buy |
165,290
+5,700
| +4% | +$181K | 0.79% | 32 |
|
|
2016
Q2 | $5.18M | Buy |
159,590
+4,400
| +3% | +$143K | 0.83% | 31 |
|
|
2016
Q1 | $4.34M | Buy |
155,190
+50,540
| +48% | +$1.41M | 0.7% | 38 |
|
|
2015
Q4 | $3.73M | Buy |
104,650
+2,140
| +2% | +$76.3K | 0.59% | 43 |
|
|
2015
Q3 | $3.39M | Buy |
102,510
+3,560
| +4% | +$118K | 0.57% | 47 |
|
|
2015
Q2 | $4.14M | Sell |
98,950
-800
| -0.8% | -$33.5K | 0.63% | 44 |
|
|
2015
Q1 | $3.25M | Buy |
99,750
+1,500
| +2% | +$48.9K | 0.49% | 48 |
|
|
2014
Q4 | $3.12M | Buy |
98,250
+450
| +0.5% | +$14.3K | 0.48% | 50 |
|
|
2014
Q3 | $2.42M | Buy |
97,800
+8,000
| +9% | +$198K | 0.39% | 66 |
|
|
2014
Q2 | $2.03M | Buy |
89,800
+11,450
| +15% | +$259K | 0.35% | 77 |
|
|
2014
Q1 | $1.91M | Buy |
78,350
+14,800
| +23% | +$360K | 0.35% | 75 |
|
|
2013
Q4 | $1.59M | Buy |
63,550
+17,000
| +37% | +$425K | 0.3% | 82 |
|
|
2013
Q3 | $1.28M | Buy |
+46,550
| New | +$1.28M | 0.26% | 89 |
|